The Ministry of Health is working on regulatory projects to provide a framework that promotes competition and ensures the viability of the biosimilars market in the long term. Javier Padilla, Secretary of State for Health, highlighted the importance of these drugs in terms of sustainability, access, innovation and clinical aspects during a conference organized by Biosim in the Congress of Deputies.